Halozyme Sues Merck Over Keytruda Patent Infringement
Halozyme Therapeutics Inc. has filed a patent infringement lawsuit against Merck over its injectable formulation of cancer immunotherapy drug Keytruda.
2 minutes to read
Halozyme Therapeutics Inc